FV Hospital uses AI for myopia control and more instructions
FV Hospital launches AI-driven myopia control service
FV Hospital, one of the largest private hospitals in Vietnam, recently introduced a myopia control program for children and adolescents aged 3 to 18 years.
The new service is designed to screen young people for myopia risk, predict future myopia levels and provide a plan to control the progression of myopia. It will be offered annually and will include screening, treatment plans and guidance on how to manage myopia, including lifestyle changes and regular three-monthly follow-ups.
At the heart of the program is Myopia Master from Australian company Myopia Profile. The device uses AI to predict and analyze the progression of myopia. FV ophthalmologists use the analysis to tailor myopia control protocols to their patients.
In addition to Myopia Master, the program is also supported by the Pentacam refractive measurement system, which evaluates the curvature, thickness and condition of the cornea and detects congenital corneal diseases.
Sunway Medical Center uses AI for radiology
Malaysia’s largest private quaternary hospital, Sunway Medical Centre in Sunway City, recently adopted a radiology AI solution from Australia.
Annalise.ai’s Enterprise Chest X-ray (CXR) has been integrated into the hospital’s medical imaging workflow, according to a press release. According to Annalise.ai, the technology can identify up to 124 findings on CXRs in seconds.
SMC CEO Dr. Seow Vei Ken said the AI solution will support his doctors in quickly assessing cases and prioritizing patients based on urgency.
Xiaomi supports breast cancer screening initiative in India
Consumer electronics giant Xiaomi is backing a breast cancer screening initiative by world-renowned cricketer Yuvraj Singh in India.
Singh’s non-profit foundation, YouWeCan, is implementing the Swasth Mahila Swasth Bharat project, which aims to screen 150,000 women in 15 Indian states for breast cancer within a year. It also aims to increase awareness of breast cancer risk and self-assessment, and ensure early detection and timely delivery of treatment.
Without giving many details, Xiaomi said it will leverage its technological expertise in delivering community-based screening large communities.